# US 2024/0197686 A1 · Anti-tumoral effective benzimidazole zinc complexes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0197686 A1
- Document ID: US20240197686A1
- Status: Published application
- Kind: A1
- Application number: 18/287,185
- Filed: 2022-11-10
- Published: 2024-06-20
- Earliest claimed: 2022-11-10
- Assignees: Inonu Universitesi Rektorlugu
- Applicants: Inonu Universitesi Rektorlugu
- Inventors: Elif APOHAN; Ozfer YESILADA; Hasan KUCUKBAY; Ozgur KATRANCIOGLU; Hakan PARLAKPINAR; Mehmet GUL; Ulku YILMAZ; Yusuf BARAN
- Web page: https://patentgrep.com/patent/US20240197686A1

## CPC

- A61K 31/4184: condensed with carbocyclic rings, e.g. benzimidazoles
- A61P 35/00: Antineoplastic agents
- C07D 235/08: Radicals containing only hydrogen and carbon atoms
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

Invention relates to use of antitumoral effective benzimidazole metal complex containing zinc having antitumoral effect, in treatment of cancer. The invention particularly relates to use of 1-(4-chlorobenzyl)benzimidazole and 1-(4-methylbenzyl)benzimidazole zinc complexes in in vivo cancer treatment

## Claims

### Claim 1

Use of antitumoural effective benzimidazole metal complexes comprising zinc in treatment of cancer.

### Claim 2 (depends on 1)

A compound according to claim 1, characterized in that; it is selecting from 1-(4-chlorobenzyl)benzimidazole and 1-(4-metilbenzyl)benzimidazole zinc complexes.

### Claim 3 (depends on 1)

The compound according to claim 1, characterized in that; used in in vivo cancer treatment.

### Claim 4

A pharmaceutical composition comprising of zinc based benzimidazole metal complex compounds characterized in that; used in cancer treatment.
